Clinical Trial Update: Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics-based dosing of mycophenolate mofetil to prevent graft-versus-host disease in allogeneic hematopoietic stem cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University of Pittsburgh | Conditions: Allogeneic Blood and Marrow Transplantation (BMT), Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-06-21